Zealand Pharma A/S
ZLDPF
$65.16
$1.802.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -156.38M | -153.01M | -102.93M | -107.37M | -101.97M |
| Total Depreciation and Amortization | 3.36M | 3.36M | 3.06M | 3.95M | 2.93M |
| Total Amortization of Deferred Charges | 2.36M | 172.70K | 172.70K | 172.70K | 172.70K |
| Total Other Non-Cash Items | -622.20K | 13.70M | 14.34M | 26.18M | 29.73M |
| Change in Net Operating Assets | 17.42M | 36.28M | 12.92M | 12.33M | 7.25M |
| Cash from Operations | -135.26M | -100.87M | -73.81M | -66.12M | -61.89M |
| Capital Expenditure | -1.45M | -2.26M | -2.34M | -1.98M | -1.63M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.08B | -1.10B | -178.40M | -349.13M | -158.11M |
| Cash from Investing | -1.08B | -1.10B | -180.75M | -351.11M | -159.74M |
| Total Debt Issued | 369.87M | 369.87M | 369.87M | 369.87M | -- |
| Total Debt Repaid | -16.44M | -20.49M | -18.99M | -544.28M | -543.43M |
| Issuance of Common Stock | 8.52B | 8.54B | 8.54B | 3.01B | 1.56B |
| Repurchase of Common Stock | -351.83M | -351.83M | -81.03M | -41.60M | -41.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -236.58M | -237.06M | -234.71M | -94.86M | -71.91M |
| Cash from Financing | 1.20B | 1.20B | 1.24B | 393.34M | 132.45M |
| Foreign Exchange rate Adjustments | 893.10K | -626.40K | 430.60K | 474.20K | -1.03M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 100.00 | -- | -- |
| Net Change in Cash | -15.57M | -1.82M | 985.56M | -23.42M | -90.21M |